-
Characteristics of diabetic ketoacidosis in adult patients in Bahrain
Husain Taha Radhi*, Maryam Abdalla El-Amin*, Aysha Asif Sarwani*, Fatema Husain Mandeel*
Research Article: Clinical Investigation
-
Characteristics of diabetic ketoacidosis in adult patients in Bahrain
Husain Taha Radhi*, Maryam Abdalla El-Amin*, Aysha Asif Sarwani*, Fatema Husain Mandeel*
Research Article: Clinical Investigation
-
Characteristics of diabetic ketoacidosis in adult patients in Bahrain
Husain Taha Radhi*, Maryam Abdalla El-Amin*, Aysha Asif Sarwani*, Fatema Husain Mandeel*
Research Article: Clinical Investigation
-
Characteristics of diabetic ketoacidosis in adult patients in Bahrain
Husain Taha Radhi*, Maryam Abdalla El-Amin*, Aysha Asif Sarwani*, Fatema Husain Mandeel*
Research Article: Clinical Investigation
-
Characteristics of diabetic ketoacidosis in adult patients in Bahrain
Husain Taha Radhi*, Maryam Abdalla El-Amin*, Aysha Asif Sarwani*, Fatema Husain Mandeel*
Research Article: Clinical Investigation
-
Characteristics of diabetic ketoacidosis in adult patients in Bahrain
Husain Taha Radhi*, Maryam Abdalla El-Amin*, Aysha Asif Sarwani*, Fatema Husain Mandeel*
Research Article: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Considerations in the design of clinical trials of antibacterial agents for ventilator-associated pneumonia
John Muscedere
Review Article: Clinical Investigation
-
Considerations in the design of clinical trials of antibacterial agents for ventilator-associated pneumonia
John Muscedere
Review Article: Clinical Investigation
-
Considerations in the design of clinical trials of antibacterial agents for ventilator-associated pneumonia
John Muscedere
Review Article: Clinical Investigation
-
Considerations in the design of clinical trials of antibacterial agents for ventilator-associated pneumonia
John Muscedere
Review Article: Clinical Investigation
-
Considerations in the design of clinical trials of antibacterial agents for ventilator-associated pneumonia
John Muscedere
Review Article: Clinical Investigation
-
Considerations in the design of clinical trials of antibacterial agents for ventilator-associated pneumonia
John Muscedere
Review Article: Clinical Investigation
-
Strategies to treat sepsis: old and new
Steven P LaRosa, Steven M Opal
Therapeutic Prospective: Clinical Investigation
-
Strategies to treat sepsis: old and new
Steven P LaRosa, Steven M Opal
Therapeutic Prospective: Clinical Investigation
-
Strategies to treat sepsis: old and new
Steven P LaRosa, Steven M Opal
Therapeutic Prospective: Clinical Investigation
-
Strategies to treat sepsis: old and new
Steven P LaRosa, Steven M Opal
Therapeutic Prospective: Clinical Investigation
-
Strategies to treat sepsis: old and new
Steven P LaRosa, Steven M Opal
Therapeutic Prospective: Clinical Investigation
-
Strategies to treat sepsis: old and new
Steven P LaRosa, Steven M Opal
Therapeutic Prospective: Clinical Investigation